✦ LIBER ✦

On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia

✍ Scribed by Feldman, E J; Cortes, J; DeAngelo, D J; Holyoake, T; Simonsson, B; O'Brien, S G; Reiffers, J; Turner, A R; Roboz, G J; Lipton, J H

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FLT3 mutations in myelodysplastic syndro

✍ Daver, Naval; Strati, Paolo; Jabbour, Elias; Kadia, Tapan; Luthra, Raja; Wang, S 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

Chronic inflammatory demyelinating polyn

✍ Atsushi Isoda; Atsushi Sakurai; Yoshiyuki Ogawa; Yuri Miyazawa; Akio Saito; Mori 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 244 KB

SETBP1 mutations in 658 patients with my

✍ Damm, F; Itzykson, R; Kosmider, O; Droin, N; Renneville, A; Chesnais, V; Gelsi-B 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 274 KB

Decitabine in myelodysplastic syndromes

✍ Iastrebner, Marcelo; Jang, Jun Ho; Nucifora, Elsa; Kim, Kihyun; Sackmann, Federi 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 456 KB

Loss of heterozygosity identifies geneti

✍ O'Malley, Dennis P; Orazi, Attilio; Dunphy, Cherie H; Coleman, Benjamin R; Marks 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 96 KB

Activity of 9-nitro-camptothecin, an ora

✍ Alfonso Quintas-Cardama; Hagop Kantarjian; Susan O'Brien; Elias Jabbour; Francis 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB